Details for New Drug Application (NDA): 062483
✉ Email this page to a colleague
NDA 062483 describes GRIFULVIN V, which is a drug marketed by Johnson And Johnson, Valeant Luxembourg, and J And J, and is included in four NDAs. Additional details are available on the GRIFULVIN V profile page.
The generic ingredient in GRIFULVIN V is griseofulvin, microsize. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the griseofulvin, microsize profile page.
The generic ingredient in GRIFULVIN V is griseofulvin, microsize. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the griseofulvin, microsize profile page.
Summary for 062483
| Tradename: | GRIFULVIN V |
| Applicant: | Valeant Luxembourg |
| Ingredient: | griseofulvin, microsize |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jan 26, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
